Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.537 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.531 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.529 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.528 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.520 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.518 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.512 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.503 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.493 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.473 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.466 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.451 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.441 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 |